Received: 3 February 2021
Accepted: 3 May 2021
First Online: 17 May 2021
: This clinical field study was conducted in compliance with local and national regulatory requirements in France, Germany and Hungary and is consistent with the principles of Good Clinical Practices (VICH guideline on good clinical practice [GCP; VICH GL 9]), cited VICH referenced anthelmintic guidelines as well as cited and referenced World Association for the Advancement of Veterinary Parasitology (WAAVP) anthelmintic guidelines. Participating dog owners were required to sign an informed consent form for their dog(s) to participate in the study after details of the study design and products under investigation had been explained.
: Not applicable.
: These studies were funded by Elanco Animal Health. All authors are current or former employees of Elanco Animal Health. The handling editors have been involved in consulting services (Filipe Dantas-Torres), research projects (Filipe Dantas-Torres, Adnan Hodži#) and meetings (Filipe Dantas-Torres) sponsored by different veterinary pharmaceutical companies in the past 10 years, including Elanco. They declare that each manuscript in this collection was handled impartially and peer reviewed rigorously by at least two independent external reviewers.